Login
Companies $STE
$261.91 +$0.00 (0.0%) After hours
STERIS plc logo

STERIS plc

steris.com

What Do They Do?

Sells infection-prevention products and equipment, and provides related services, to healthcare providers, medical device makers and pharmaceutical manufacturers.

How Do They Make Money?

Customers buy products that STERIS delivers by shipment or, for some equipment, after installation is complete. Customers pay for services when work is completed; outsourced reprocessing and maintenance agreements are paid over their terms.

revenue
SegmentShareRevenue
Product
Sold outright

52%
FY2023: 52%
Service
Mix

48%
FY2023: 48%

Who Are Their Customers?

Healthcare providers buy equipment, consumables and services; medical device and pharmaceutical manufacturers buy sterilization, testing and equipment. Customers buy through dealers, distributors or group purchasing organizations as well as by purchase orders and direct agreements.

Do Revenues Turn Into Profits?

Yes. It kept 13 cents of every revenue dollar as net income in FY2026 and turned 16 cents into free cash flow.

Operating income, FY2026
19% of revenue
▲ +27% vs FY2025 ($866.6M, 16%)
Net income, FY2026
13% of revenue
▲ +27% vs FY2025 ($614.6M, 11%)
Free cash flow, FY2026
16% of revenue
▲ +25% vs FY2025 ($778M, 14%)

How Are They Changing?

Since the FY2026 annual report
Latest quarter: Q2 FY2027, the three months to Sep 30, 2026
Revenue
▲ +9%
vs $1.5B in Q2 FY2026
Net income
▲ +11%
vs $191.9M in Q2 FY2026
Product share of revenue vs 51.0% in Q2 FY2026
  • Nov 4, 2026 Raised fiscal 2027 adjusted earnings outlook The adjusted earnings-per-share range rose to $11.35 to $11.55 from $11.10 to $11.30, including tariff-refund benefits.
  • Oct 11, 2026 Agreed to acquire Xodus Medical for $2.1 billion The specialty surgical products acquisition is expected to close by December 31, 2026, subject to conditions and approvals.

Growing. Revenue grew 41% in 4 years, from $4.2B in FY2022 to $5.9B in FY2026, about 9% a year.

Dental divestiture The latest report no longer includes the Dental segment, following its sale; the older report described dental instruments, infection-prevention products and instrument-management systems for dental practitioners and schools.

AST offering The older report described AST mainly as a contract sterilization and testing provider; the latest report also describes integrated sterilization equipment and control systems as part of its offering.

Revenue over time
Product Service
$10B$5B$0

Who Do They Compete With?

Competes with 3M, Baxter, Boston Scientific, Belimed, Ecolab, Fortive, Getinge, Karl Storz, Olympus, Ruhof, SteelCo, Stryker, Skytron, Wassenburg, BBraun, Pentax, Sterigenics, Contec, Fedegari, and Stilmas

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support